| The Pharmaceutical Journal |
|
News summary |
| Related websites |
Early aspirin improves survivalEarly treatment with aspirin improves survival after coronary bypass surgery, say American researchers. They studied just over 5,000 patients and found that among those treated with aspirin within 48 hours of surgery, the rate of death was more than 60 per cent lower than it was in those who were not (1.3 per cent versus 4.0 per cent, P<0.001). The rates of non-fatal ischaemic complications, including myocardial infarction, stroke, renal failure and bowel infarction, were each reduced by a similar magnitude (New England Journal of Medicine 2002; 347:1309). |
Home | Journals | News | Notice-board | Search | Jobs Classifieds | Site
Map | Contact us
©The Pharmaceutical Journal